{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T00:02:27Z","timestamp":1791590547256,"version":"4.3.4"},"reference-count":41,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:00:00Z","timestamp":1764028800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004083","name":"Ministry of Science ICT and Future Planning","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004083","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2020R1F1A1069718"],"award-info":[{"award-number":["NRF-2020R1F1A1069718"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ero.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["EULAR Rheumatology Open"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.ero.2025.11.022","type":"journal-article","created":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T10:59:25Z","timestamp":1767092365000},"page":"69-78","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Blood-based gene signatures associated with therapeutic response to anti-TNF therapy in rheumatoid arthritis: a combined meta-analytical and machine learning approach"],"prefix":"10.1016","volume":"2","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1014-1336","authenticated-orcid":false,"given":"Yoonjung","family":"Choi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taeseong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun Jeong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daeyoup","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung Eun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ero.2025.11.022_bib0001","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1016\/S0140-6736(07)60784-3","article-title":"New therapies for treatment of rheumatoid arthritis","volume":"370","author":"Smolen","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.ero.2025.11.022_bib0002","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1056\/NEJM200011303432202","article-title":"Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-tumor necrosis factor trial in rheumatoid arthritis with concomitant therapy study group","volume":"343","author":"Lipsky","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ero.2025.11.022_bib0003","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1136\/annrheumdis-2011-200395","article-title":"Tocilizumab inhibits progression of joint damage in rheumatoid arthritis irrespective of its anti-inflammatory effects: disassociation of the link between inflammation and destruction","volume":"71","author":"Smolen","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ero.2025.11.022_bib0004","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1136\/annrheumdis-2016-210715","article-title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update","volume":"76","author":"Smolen","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ero.2025.11.022_bib0006","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/art.23721","article-title":"American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis","volume":"59","author":"Saag","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"9","key":"10.1016\/j.ero.2025.11.022_bib0007","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1136\/ard.2007.083675","article-title":"The effectiveness and medication costs of three anti-TNF agents\u03b1 in the treatment of rheumatoid arthritis from prospective clinical practice data","volume":"67","author":"Kievit","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ero.2025.11.022_bib0008","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/nrd2196","article-title":"Biologic therapies in rheumatology: lessons learned, future directions","volume":"6","author":"Strand","year":"2007","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.ero.2025.11.022_bib0009","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1093\/rheumatology\/ken083","article-title":"Messenger ribonucleic acid expression profile in peripheral blood cells from RA patients following treatment with an anti-TNF-\u03b1 monoclonal antibody, infliximab","volume":"47","author":"Sekiguchi","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.ero.2025.11.022_bib0010","doi-asserted-by":"crossref","first-page":"R105","DOI":"10.1186\/ar1990","article-title":"Gene profiling in white blood cells predicts infliximab responsiveness in rheumatoid arthritis","volume":"8","author":"Lequerr\u00e9","year":"2006","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.ero.2025.11.022_bib0011","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0033199","article-title":"Validation study of existing gene expression signatures for anti-TNF treatment in patients with rheumatoid arthritis","volume":"7","author":"Toonen","year":"2012","journal-title":"PLOS ONE"},{"key":"10.1016\/j.ero.2025.11.022_bib0012","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ddstr.2006.02.004","article-title":"Biomarkers: strategies to predict outcome of rheumatoid arthritis","volume":"3","author":"Saleem","year":"2006","journal-title":"Drug Discov Today Ther Strateg"},{"key":"10.1016\/j.ero.2025.11.022_bib0013","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1093\/rheumatology\/kel149","article-title":"Predictors of response to anti-TNF-\u03b1 therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register","volume":"45","author":"Hyrich","year":"2006","journal-title":"Rheumatology (Oxford)."},{"key":"10.1016\/j.ero.2025.11.022_bib0014","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/gm463","article-title":"Peripheral blood derived gene panels predict response to infliximab in rheumatoid arthritis and Crohn\u2019s disease","volume":"5","author":"Mesko","year":"2013","journal-title":"Genome Med"},{"key":"10.1016\/j.ero.2025.11.022_bib0015","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1186\/s13075-019-1999-3","article-title":"Molecular profiling of rheumatoid arthritis patients reveals an association between innate and adaptive cell populations and response to anti-tumor necrosis factor","volume":"21","author":"Farutin","year":"2019","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.ero.2025.11.022_bib0016","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s13075-019-1862-6","article-title":"Gene expression analysis of vascular pathophysiology related to anti-TNF treatment in rheumatoid arthritis","volume":"21","author":"P\u00f3liska","year":"2019","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.ero.2025.11.022_bib0017","doi-asserted-by":"crossref","first-page":"e7556","DOI":"10.1371\/journal.pone.0007556","article-title":"An eight-gene blood expression profile predicts the response to infliximab in rheumatoid arthritis","volume":"4","author":"Juli\u00e0","year":"2009","journal-title":"PLOS ONE"},{"key":"10.1016\/j.ero.2025.11.022_bib0018","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.bbrc.2009.06.149","article-title":"Prediction of efficacy of anti-TNF biologic agent, infliximab, for rheumatoid arthritis patients using a comprehensive transcriptome analysis of white blood cells","volume":"387","author":"Tanino","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.ero.2025.11.022_bib0019","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1038\/s41467-018-05044-4","article-title":"Multi-omics monitoring of drug response in rheumatoid arthritis in pursuit of molecular remission","volume":"9","author":"Tasaki","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.ero.2025.11.022_bib0020","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s13075-016-1052-8","article-title":"Identification of baseline gene expression signatures predicting therapeutic responses to three biologic agents in rheumatoid arthritis: a retrospective observational study","volume":"18","author":"Nakamura","year":"2016","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.ero.2025.11.022_bib0021","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/tpj.2013.48","article-title":"Gene expression analysis in RA: towards personalized medicine","volume":"14","author":"Burska","year":"2014","journal-title":"Pharmacogenomics J"},{"key":"10.1016\/j.ero.2025.11.022_bib0022","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1093\/rheumatology\/keu299","article-title":"Interferon gene expression signature in rheumatoid arthritis neutrophils correlates with a good response to TNFi therapy","volume":"54","author":"Wright","year":"2015","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.ero.2025.11.022_bib0023","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1002\/art.27226","article-title":"Association of the response to tumor necrosis factor antagonists with plasma type I interferon activity and interferon-\u03b2\/\u03b1 ratios in rheumatoid arthritis patients: a post hoc analysis of a predominantly Hispanic cohort","volume":"62","author":"Mavragani","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ero.2025.11.022_bib0024","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0281637","article-title":"Deciphering novel common gene signatures for rheumatoid arthritis and systemic lupus erythematosus by integrative analysis of transcriptomic profiles","volume":"18","author":"Tyagi","year":"2023","journal-title":"PLOS ONE"},{"key":"10.1016\/j.ero.2025.11.022_bib0025","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3389\/fimmu.2017.00074","article-title":"A comprehensive gene expression meta-analysis identifies novel immune signatures in rheumatoid arthritis patients","volume":"8","author":"Afroz","year":"2017","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.ero.2025.11.022_bib0026","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1002\/art.30129","article-title":"American College of Rheumatology\/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials","volume":"63","author":"Felson","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ero.2025.11.022_bib0027","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1093\/bioinformatics\/btu170","article-title":"Trimmomatic: a flexible trimmer for Illumina sequence data","volume":"30","author":"Bolger","year":"2014","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ero.2025.11.022_bib0028","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ero.2025.11.022_bib0029","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.molcel.2010.05.004","article-title":"Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities","volume":"38","author":"Heinz","year":"2010","journal-title":"Mol Cell"},{"key":"10.1016\/j.ero.2025.11.022_bib0030","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol"},{"key":"10.1016\/j.ero.2025.11.022_bib0031","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/art.1780390105","volume":"39","author":"van Gestel","year":"1996","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ero.2025.11.022_bib0032","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1093\/bioinformatics\/btg155","article-title":"A comparison of parametric versus permutation methods with applications to general and temporal microarray gene expression data","volume":"19","author":"Xu","year":"2003","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ero.2025.11.022_bib0033","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/345106","article-title":"Comparison of merging and meta-analysis as alternative approaches for integrative gene expression analysis","volume":"2014","author":"Taminau","year":"2014","journal-title":"ISRN Bioinform"},{"key":"10.1016\/j.ero.2025.11.022_bib0034","doi-asserted-by":"crossref","first-page":"e184","DOI":"10.1371\/journal.pmed.0050184","article-title":"Key issues in conducting a meta-analysis of gene expression microarray datasets","volume":"5","author":"Ramasamy","year":"2008","journal-title":"PLOS Med"},{"key":"10.1016\/j.ero.2025.11.022_bib0035","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1180642","article-title":"Towards unravelling biological mechanisms behind radiation-induced oral mucositis via mass spectrometry-based proteomics","volume":"13","author":"Subedi","year":"2023","journal-title":"Front Oncol"},{"key":"10.1016\/j.ero.2025.11.022_bib0036","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.3390\/microorganisms11082101","article-title":"Type I interferon pathway-related hub genes as a potential therapeutic target for SARS-CoV-2 omicron variant-induced symptoms","volume":"11","author":"Lin","year":"2023","journal-title":"Microorganisms"},{"issue":"1","key":"10.1016\/j.ero.2025.11.022_bib0037","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e41342","article-title":"Mapping integral cell-type-specific interferon-induced gene regulatory networks (GRNs) involved in systemic lupus erythematosus using systems and computational analysis","volume":"11","author":"Kiruba","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.ero.2025.11.022_bib0038","series-title":"Statistical power analysis for the behavioral sciences","first-page":"20","author":"Cohen","year":"2013"},{"key":"10.1016\/j.ero.2025.11.022_bib0039","unstructured":"Lee K.E., Choi Y.J., Kim H.J., et al. Biomarkers for predicting TNF inhibitor drug responsiveness in Koreans. Korean Patent KR102429261B1. August 4, 2022."},{"key":"10.1016\/j.ero.2025.11.022_bib0040","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1023\/A:1010933404324","article-title":"Random forests","volume":"45","author":"Breiman","year":"2001","journal-title":"Mach Learn"},{"key":"10.1016\/j.ero.2025.11.022_bib0041","series-title":"Proceedings of the 22nd ACM SIGKDD International Conference on Knowledge Discovery and Data Mining","first-page":"785","article-title":"Xgboost: a scalable tree boosting system","author":"Chen","year":"2016"},{"key":"10.1016\/j.ero.2025.11.022_bib0042","doi-asserted-by":"crossref","first-page":"5531","DOI":"10.1038\/s41467-025-60445-6","article-title":"Type 1 interferon signature and allograft inflammatory factor-1 contribute to refractoriness to TNF inhibition in ankylosing spondylitis","volume":"16","author":"Song","year":"2025","journal-title":"Nat Commun"}],"container-title":["EULAR Rheumatology Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S3050708125001223?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S3050708125001223?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T03:53:46Z","timestamp":1787716426000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S3050708125001223"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S3050708125001223"],"URL":"https:\/\/doi.org\/10.1016\/j.ero.2025.11.022","relation":{},"ISSN":["3050-7081"],"issn-type":[{"value":"3050-7081","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Blood-based gene signatures associated with therapeutic response to anti-TNF therapy in rheumatoid arthritis: a combined meta-analytical and machine learning approach","name":"articletitle","label":"Article Title"},{"value":"EULAR Rheumatology Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ero.2025.11.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V. on behalf of European Alliance of Associations for Rheumatology (EULAR).","name":"copyright","label":"Copyright"}]}}